Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis
2007
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
In silico prediction of protein-protein interactions in human macrophages
2014 Standout
Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996–2001). Description of new mutations in the rpoB gene and review of the literature
2003
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
Monocyte recruitment during infection and inflammation
2011 Standout
Inflammation and metabolic disorders
2006 StandoutNature
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia
2005
Population biological principles of drug-resistance evolution in infectious diseases
2011
Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy
2004
Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
2009
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols
2021 StandoutNobel
Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results
1992
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
The Science of Antibiotic Discovery
2020 Standout
Global Trends in Resistance to Antituberculosis Drugs
2001
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Global Burden of Tuberculosis
1999 Standout
Biofilms: an emergent form of bacterial life
2016 Standout
The Regulation of Sulfur Metabolism in Mycobacterium tuberculosis
2011 StandoutNobel
Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults
1997
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
2007 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
2019 StandoutNobel
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface
2015 StandoutNobel
Use of Mycobacterial Smears in the Diagnosis of Pulmonary Tuberculosis in AIDS/ARC Patients
1989
Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products
2001
Revisiting the timetable of tuberculosis
2018
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
1993 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Quantitative Bacillary Response to Treatment in HIV-associated Pulmonary Tuberculosis
1993
Antibiotic resistance in the environment
2021 Standout
Simple Procedure for Drug Susceptibility Testing of Mycobacterium tuberculosis Using a Commercial Colorimetic Assay
1999
A Comparison of Outbreak‐ and Nonoutbreak‐Related Multidrug‐Resistant Tuberculosis Among Human Immunodeficiency Virus–Infected Patients in a South African Hospital
1999
Nosocomial Spread of Human Immunodeficiency Virus‐Related Multidrug‐Resistant Tuberculosis in Buenos Aires
1997
Biphasic Kill Curve of Isoniazid Reveals the Presence of Drug‐Tolerant, Not Drug‐Resistant,Mycobacterium tuberculosisin the Guinea Pig
2009
Leprosy
2004 Standout
Prediction of antibiotic resistance: time for a new preclinical paradigm?
2017
A Riboswitch-Based Inducible Gene Expression System for Mycobacteria
2012 StandoutNobel
The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection
1997
The global situation of MDR-TB
2003
Spectrum of drugs against atypical mycobacteria: How valid is the current practice of drug susceptibility testing and the choice of drugs?
1992
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Fighting tuberculosis: An old disease with new challenges
2004
Treatment of Multidrug-Resistant Tuberculosis
1993
Molecular detection, identification and drug resistance detection inMycobacterium tuberculosis: Table 1
2009
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay
1995
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
2007 Standout
A Model for Tuberculosis with Exogenous Reinfection
2000
Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
2002 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Characterization and Transcriptome Analysis of Mycobacterium tuberculosis Persisters
2011
CD4+cell-dependent granuloma formation in humanized mice infected with mycobacteria
2013
Immunology of Tuberculosis
2001 Standout
The pattern of resistance development to rifampicin in mycobacterium tuberculosis
1972
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Catalytic Asymmetric Synthesis of Phthioceranic Acid, a Heptamethyl-Branched Acid from Mycobacterium tuberculosis
2007 StandoutNobel
Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research
2007 Standout
Drug resistance in leprosy - a review
1985
Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
2009
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
1995
Risk factors for acquired multidrug-resistant tuberculosis
2003
Use of 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium Bromide for Rapid Detection of Rifampin-ResistantMycobacterium tuberculosis
1998
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis
1981
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Actions of the rifamycins
1971
Population Biology, Evolution, and Infectious Disease: Convergence and Synthesis
1999 Science
Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
1998
Some observations on the genetics of isoniazid resistance in the tubercle bacilli.
1971
Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
2014
Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages
1993
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
2004
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
The Immune Response in Tuberculosis
2013 Standout
Nonreplicating Persistence ofMycobacteriumTuberculosis
2001
In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex
1989
Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century.
1999
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Multidrug-resistantMycobacterium tuberculosisin HIV-Infected Persons, Peru
2003
Prospective study of mycobacterial infections in patients with cystic fibrosis.
1990
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
2007
MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs
1988
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology
1997 Standout
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Origins and Evolution of Antibiotic Resistance
2010 Standout
The development of clinical tuberculosis following infection with tubercle bacilli
1982
Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing.
1987
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
1997 Standout
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
2007
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Chemokine receptor 2 serves an early and essential role in resistance toMycobacterium tuberculosis
2001
Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis
2008
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis
2002 Standout
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Macrophage Apoptosis in Tuberculosis
2009
Works of G Canetti being referenced
Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis.
1972
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.
1963
[Rifomycin levels in the lung and tuberculous lesions in man].
1969
PATHOGENESIS OF TUBERCULOSIS IN MAN
1968
Dynamic aspects of the pathology and bacteriology of tuberculous lesions.
1956
Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in france from 1962 to 1970: A national survey
1972
THE TUBERCLE BACILLUS IN THE PULMONARY LESION OF MAN
1956
PRIMARY DRUG RESISTANCE IN TUBERCULOSIS.
1964
Studies of bacillary populations in experimental tuberculosis of mice treated by isoniazid.
1960
Some comparative aspects of rifampicin and isoniazid
1968
Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.
1969
Present aspects of bacterial resistance in tuberculosis.
1965